News Author: Erik Greb Publish date: October 15, 2022
The chronic neurologic disorder entails not only excessive sleepiness but also social and professional challenges.
News Author: Erik Greb Publish date: February 22, 2022
“Endovascular treatment using Onyx is able to achieve, on its own, a very efficient cure rate with a low morbidity and mortality rate,”
News Author: Erik Greb Publish date: February 18, 2022
Median Modified Rankin Scale (mRS) score at 90 days was 3 in both patients who received tirofiban and those who received placebo.
News Author: Erik Greb Publish date: February 1, 2022
The drug also was associated with improved daytime function.
News Author: Erik Greb Publish date: January 10, 2022
The safety of outpatient care can be improved by correct risk stratification, then triaging patients based on their risk profile.
News Author: Erik Greb Publish date: January 10, 2022
Whereas the overall results are very positive, the improvements in daytime functioning are especially “exciting.”
News Author: Erik Greb Publish date: December 15, 2021
Diabetes is associated with a higher risk for incident Parkinson’s disease and with worse motor symptoms, more rapid disease progression, new resea...
News Author: Erik Greb Publish date: November 12, 2021
The rate of good functional outcome was 57% for patients who underwent direct thrombectomy and 65% among patients who received IV thrombolysis befo...
News Author: Erik Greb Publish date: October 25, 2021
“He was always thinking creatively; he was always thinking intellectually,” said Angela Hill, widow of Dr. Irwin Marcus. “That was, to me, the marv...
News Author: Erik Greb Publish date: October 19, 2021
The risk for a first relapse was 6 times higher in patients receiving interferon beta or glatiramer acetate, compared with those receiving rituxima...
News Author: Erik Greb Publish date: October 15, 2021
High numbers of cortical lesions at diagnosis are indicative of a more serious disease course.
News Author: Erik Greb Publish date: October 5, 2021
Methylphenidate provides a “modest but potentially clinically significant benefit for patients and caregivers,” said Dr. Jacobo Mintzer and associa...
News Author: Erik Greb Publish date: September 29, 2021
With this approval, neurologists will be able to choose from four monoclonal antibodies and two gepants for the preventive treatment of migraine.
News Author: Erik Greb Publish date: September 16, 2021
New data show that aspirin and heparin, alone or in combination, double the risk for symptomatic intracranial hemorrhage when given during endovasc...
News Author: Erik Greb Publish date: September 3, 2021
“Larger studies with more specified population are needed to further assess safety and efficacy of tranexamic acid in patients with ICH.”
